Portage Biotech Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Portage Biotech Inc
Access all reports
Portage Biotech Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative immuno-oncology treatments. The company is focused on advancing first-in-class therapies that target checkpoint resistance pathways, with the goal of achieving durable treatment responses and improving the quality of life for patients with cancer. Portage Biotech's approach aims to address the limitations of current cancer therapies by offering potentially more effective treatment options. The company's research and development efforts are concentrated on novel multi-targeted therapies that can be used both as monotherapies and in combination with other treatments to combat cancer more effectively. The company is headquartered in Westport, Connecticut, and its shares are listed on the Nasdaq.
Latest articles
The Art of Portfolio Management: Lessons from Tom O'Hara
Tom O'Hara shares insights on stock picking, navigating market distractions, and the importance of one-on-one meetings with management teams.
4 Oct 2024
The Samsung Co-CEOs: Jong-Hee Han & Young-Hyun Jun
Samsung Electronics' dual-CEO structure, led by Jong-Hee Han and Young-Hyun Jun, is designed to navigate the complexities of its diverse business.
3 Oct 2024
Irwin Jacobs & Andrew Viterbi: Qualcomm's Pioneering Founders
In 1985, Irwin Jacobs and Andrew Viterbi co-founded Qualcomm, a leading company in telecommunications and semiconductor innovation.
3 Oct 2024
Ticker symbol
PRTG
Country
🇺🇸 United States